Business innovation

Despite safe and effective vaccines being available for a wide range of infectious diseases, prevention and treatment of more complex conditions, including allergy and cancer, remain elusive. Furthermore, vaccines are complex to manufacture, making them difficult to produce to a scale, quality and cost that supports widespread global access. An ongoing collaboration between South Australian biotech company Sementis Ltd and UniSA’s Experimental Therapeutics Laboratory has developed a vaccine delivery platform that can potentially produce easy-to-manufacture vaccines for multiple acute and chronic disease conditions.

Minerals processing machinery is expensive and endures extreme levels of erosion, corrosion, and wear and tear induced by repetitive impact. Shutdowns for repairs and maintenance of equipment can cost more than $100,000 for every hour of downtime.

Australian surface engineering company, LaserBond, and UniSA’s specialist Coatings Research Group at the Future Industries Institute, are developing some of the world’s most resilient minerals processing equipment through the use of composite coatings and laser cladding.